Product Information
VIGAMOX 0.5% EYE DROPS is a brand product labeled by Harrow Eye, LLC, priced at $31.8080 per ML under NDC 82667070003. Its NADAC has been published 99 times since Nov 13, 2024.
FDA first approved this application on Apr 15, 2003. Its Orange Book therapeutic-equivalence code is AT1.
The High Outlier badge above means this manufacturer's average price in the moxifloxacin hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
5 mg/mL
Manufacturer
Harrow Eye, LLCNDC
82667070003
Classification
Brand
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
6/17/2026
Active Ingredients
MOXIFLOXACIN HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA021598FDA Approved
4/15/2003
TE Code
AT1
On Market Since
7/1/2024
Pharmacological Classes
Price Statistics
The NADAC for VIGAMOX 0.5% EYE DROPS has been published 99 times since Nov 13, 2024, and over the history we have for it it has declined 50.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $31.8080 per ML |
|---|---|
| All-time high | $63.9661 (Nov 13, 2024) |
| All-time low | $31.5167 (Nov 20, 2024) |
| 52-week high | $31.8080 |
| 52-week low | $31.5167 |
| Median price | $31.7060 |
| Average price | $31.9673 |
| Largest weekly change | -50.7% (Nov 20, 2024) |
| Weeks tracked | 99 |
| Tracking since | Nov 13, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 95% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Harrow Eye, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
moxifloxacin hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Fluoroquinolone Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of VIGAMOX 0.5% EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for VIGAMOX 0.5% EYE DROPS, manufactured by Harrow Eye, LLC, is $31.8080 per ML (NDC 82667070003), effective Sep 30, 2026.
How has the price of VIGAMOX 0.5% EYE DROPS changed over time?
Over the history we have for it, the NADAC for VIGAMOX 0.5% EYE DROPS has declined 50.3%. It has been tracked across 99 weekly CMS publications since Nov 13, 2024.
What are the highest and lowest recorded NADAC prices for VIGAMOX 0.5% EYE DROPS?
Since Nov 13, 2024, the NADAC for VIGAMOX 0.5% EYE DROPS has ranged from a low of $31.5167 (Nov 20, 2024) to a high of $63.9661 (Nov 13, 2024), with a median of $31.7060 per ML.
Are there cheaper alternatives to VIGAMOX 0.5% EYE DROPS?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, MOXIFLOXACIN 0.5% EYE DROPS, is $1.5963 per ML — about 95% below VIGAMOX 0.5% EYE DROPS.
Who manufactures VIGAMOX 0.5% EYE DROPS?
VIGAMOX 0.5% EYE DROPS (NDC 82667070003) is labeled by Harrow Eye, LLC, and CMS classifies it as a brand product.